ru-28362 has been researched along with 3,4-methylenedioxyamphetamine in 1 studies
Studies (ru-28362) | Trials (ru-28362) | Recent Studies (post-2010) (ru-28362) | Studies (3,4-methylenedioxyamphetamine) | Trials (3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (3,4-methylenedioxyamphetamine) |
---|---|---|---|---|---|
175 | 0 | 3 | 4,806 | 77 | 1,373 |
Protein | Taxonomy | ru-28362 (IC50) | 3,4-methylenedioxyamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2314 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.7129 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.996 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.6486 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lowy, MT; Meltzer, HY; Nash, JF | 1 |
1 other study(ies) available for ru-28362 and 3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Androstanols; Animals; Corpus Striatum; Corticosterone; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Serotonin | 1989 |